Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : Receives a Buy rating from Kepler Cheuvreux

11/13/2020 | 08:30am EST

Kepler Cheuvreux analyst David Evans maintains his Buy rating on the stock. The target price remains set at EUR 144.


© MarketScreener with dpa-AFX Analyser 2020
All news about MERCK KGAA
01/14KONINKLIJKE PHILIPS N : Philips Teams Up With Merck to Develop Digital Products ..
MT
01/14DGAP-PVR : Merck KGaA: Release according to -4-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to -3-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to -2-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to Article 40, Section 1 of the WpHG [t..
DJ
01/13MERCK KGAA : JP Morgan keeps its Buy rating
MD
01/11DGAP-PVR : Merck KGaA: Release according to -6-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -5-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -4-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -3-
DJ
More news
Financials
Sales 2020 17 359 M 20 961 M 20 961 M
Net income 2020 1 973 M 2 383 M 2 383 M
Net Debt 2020 11 104 M 13 408 M 13 408 M
P/E ratio 2020 32,6x
Yield 2020 0,94%
Capitalization 64 738 M 78 272 M 78 171 M
EV / Sales 2020 4,37x
EV / Sales 2021 4,07x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 137,28 €
Last Close Price 148,90 €
Spread / Highest target 13,5%
Spread / Average Target -7,81%
Spread / Lowest Target -32,2%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA6.09%78 272
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD6.24%26 461
KYOWA KIRIN CO., LTD.0.14%14 584
BETTA PHARMACEUTICALS CO., LTD.12.74%7 529
YUHAN CORPORATION1.60%4 306
RECIPHARM AB (PUBL)1.19%2 674